Showing results (71-80 of 164) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL GroupCecile Bally, Jehane Fadlallah, Guy Leverger, et al.Blood|January 24, 2012
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL studyPatrice Chevallier, Nelly Robillard, Aude Charbonnier, et al.Blood|July 29, 2010
Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)Sylvain Thepot, Raphael Itzykson, Valerie Seegers, et al.EMBO Reports|June 11, 2025
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cellsKhansa Saadallah, Benoît Vianay, Louise Bonnemay, et al.Journal of Clinical Microbiology|December 16, 2011
Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patientsAnne Bergeron, Raphaël Porcher, Jean Menotti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and olderClaude Gardin, Sylvie Chevret, Cécile Pautas, et al.Cancer|April 8, 2015
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL groupThorsten Braun, Sophie Cereja, Sylvie Chevret, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 studyFrançoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.Blood|March 8, 2007
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trialClaude Gardin, Pascal Turlure, Thierry Fagot, et al.American Journal of Hematology|January 27, 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PMMatteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, et al.Pageof 17